Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1999-05-18
2000-03-21
Jarvis, William R. A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
A61K 31495, A61K 3150
Patent
active
060403071
ABSTRACT:
Methods and compositions are disclosed utilizing the optically pure (-) isomer of ketoconazole. This compound is a potent drug for the treatment of local and systemic fungal, yeast, and dermatophyte infections, while avoiding the concomitant liability of adverse effects associated with the racemic mixture of ketoconazole.
REFERENCES:
patent: 4144346 (1979-03-01), Heeres et al.
patent: 4223036 (1980-09-01), Heeres et al.
patent: 4358449 (1982-11-01), Heeres et al.
"Antimycotic Imidazoles. Part 4. Synthesis and Antifungal Activity of Ketoconazole, a New Potent Orally Active Broad-Spectrum Antifungal Agent," by j. Heeres, L.J.J. Backx, J.H. Mostmans and J. Van Cutsem; Journal of Medicinal Chemistry, vol. 22, No. 8, (1979), pp. 1003-1005.
"Hepatic reactions associated with ketoconazole in the United Kingdom," by G Lake-Bakaar, P.J. Scheuer and S. Sherlock; British Medical Journal, vol. 294, (1987), pp. 419-422.
"1-(1-Indanyl)- and 1-(1-Tetralyl)imidazole-5-carboxylate Esters, a Novel Type of Antifungal Agents," by E.F. Godefroi, J. Van Cutsem, C.A.M. Van Der Eycken and P.A.J. Janssen; Journal Medicinal Chemistry, vol. 10, (1967), pp. 1160-1161.
"Ketoconazole--a new broad spectrum orally active antimycotic.sup.1," by D. Thienpont, J. Van Cutsem, F. Van Gerven, J. Heeres ad P.A.J. Janssen; Experientia, vol. 35, (1979), pp. 606-607.
"Stereoisomers of Ketoconazole: Preparation and Biological Activity," by D.M. Rotstein, D.J. Kertesz, K.A.M. Walker and D.C. Swinney; Journal of Medicinal Chemistry, vol. 35, (1992), pp. 2818-2825.
J.E.F. Reynolds `Matindale, The Extra Pharmacopoeia` 1989, The Pharmaceutical Press, London Press, London pp. 426--p. 429.
"cis-1-Acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1-imidazol ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine: Ketoconazole. A Crystal Structure with Disorder" by O.M. Peeters, N.M. Blaton and C.J. DeRanter; ACTA Crystallographica, vol. B35 (1979), pp. 2461-2464.
"In Vitro and In Vivo Effects of the Antimycotic Drug Ketoconazole on Sterol Synthesis" by Hugo Van Den Bossche, Gustaaf Willemsens, Willy Cools, Frans Cornelissen, William F. Lauwers, and Jan M. Van Cutsem; Antimicrobial Agents and Chemotherapy, vol. 17 Jun. (1980), pp. 922-928.
"Molecular Basis for the Antimycotic and Antibacterial Activity of N-Substituted Imidazoles and Triazoles: the Inhibition of Isoprenoid Biosynthesis", Vanden Bossche et al. Pestic. Sci 15 , 188-198 (1984).
Gray Nancy M.
Woosley Raymond Leon
Jarvis William R. A.
Sepracor Inc.
LandOfFree
Methods ad compositions of (-) ketoconazole for treating fungal does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods ad compositions of (-) ketoconazole for treating fungal , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods ad compositions of (-) ketoconazole for treating fungal will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-730520